ERRFY News and Press, Eurofins Scientific S.E. ADR From 10/15/20

The fund's investment objective is long-term growth of capital. In pursuing this objective, it focuses on investing in equity securities that the advisor believes are undervalued at the time of purchase and have the potential for growth. For Q3 2020, Sequoia Fund generated a total ret...

MURCIA, Spain , Aug. 24, 2020 /PRNewswire/ -- Eurofins Discovery is expanding its footprint to serve the growing market of outsourced drug discovery with its high-quality chemistry capabilities. Eurofins Villapharma is Eurofins Discovery's flagship center for synthetic chemistry, foc...

Original Post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...

Original post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...

FREMONT, Calif. , June 29, 2020 /PRNewswire/ -- Eurofins DiscoverX, the products company of Eurofins Discovery, today announced the expansion of their CRO Certification Program for Bioassays with Catalent Biologics as a North American provider certified in the program. As a certified prov...

MANSFIELD, Mass. , May 29, 2020 /PRNewswire/ -- Transplant Genomics Inc.  (TGI), the leader in bringing personalized diagnostics to transplant patients worldwide, announces that TGI Clinical Advisor, Dr. John Friedewald of Northwestern University will receive a top honor at the ...

MANSFIELD, Mass. , May 21, 2020 /PRNewswire/ -- Following the launch in April 2020 of Labs@Home in response to the COVID-19 pandemic began impacting transplant patient care and the world, Transplant Genomics, Inc. ("TGI"), announce today the successful growth of TruGraf® dr...

MANSFIELD, Mass. , April 15, 2020 /PRNewswire/ -- Eurofins - Transplant Genomics ("TGI"), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by genomics, today announced patient enrollment will begin in their TRULO (...

LEE'S SUMMIT, Mo. , April 8, 2020 /PRNewswire/ -- Eurofins, a global leader in testing and laboratory services, announces that Viracor Eurofins, one of the largest and most recognised infectious diseases testing laboratories in the U.S., was granted an Emergency Use Authorization (EUA) fr...

MANSFIELD, Mass. , March 18, 2020 /PRNewswire/ -- Transplant Genomics, Inc. ("TGI"), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by genomics, today announced that it has partnered with sister Eurofins company ...